Investor Alert: Investigation into Roka Bioscience, Inc. Announced by Holzer & Holzer, LLC

ATLANTA--()--Holzer & Holzer, LLC is investigating whether Roka Bioscience, Inc. (“Roka” or the “Company”) (ROKA) and/or certain of its officers complied with the federal securities laws in making public statements regarding its business and operations in connection with its recent Initial Public Offering commenced on July 17, 2014 (“IPO”). On November 6, 2014, Roka announced its third quarter 2014 financial results and admitted that the Company had not placed any of its Atlas diagnostic instruments during the quarter. The price of Roka stock fell dramatically following the announcement.

If you purchased ROKA common stock before November 7, 2014 and suffered loss on that investment, you are encouraged to contact Holzer & Holzer, LLC and its attorneys Corey D. Holzer, Esq. via email at cholzer@holzerlaw.com or via toll-free telephone at (888) 508-6832, to discuss your legal rights.

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

Contacts

Holzer & Holzer, LLC
Marshall P. Dees, Esq., (888) 508-6832 (toll-free)
mdees@holzerlaw.com

Release Summary

Holzer investigates Roka Bioscience

Contacts

Holzer & Holzer, LLC
Marshall P. Dees, Esq., (888) 508-6832 (toll-free)
mdees@holzerlaw.com